RAPAd®

The RAPAd® method of Adenovirus construction, developed by ViraQuest Inc. scientists, has been used by other scientists around the world.

Request Quote

Confidentiality

 

Learn More

Quality Control

Plaque forming units guarantee. Non-detectable RCA.

Learn More

Turnaround Time

Sub-cloning to finished particles in about four weeks.

Learn More

Dual Expressers

Multiple transgene expression in a single virus.

Learn More

Tag Archives: Vaccine

Genetic control of immune responses to influenza A matrix 2 protein (M2).

Authors: Misplon JA, Lo CY, Gabbard JD, Tompkins SM, Epstein SL.
Citation: Vaccine. 2010 Aug 16;28(36):5817-27.

read more

Development of an adenoviral vaccine against E6 and E7 oncoproteins to prevent growth of human papillomavirus-positive cancer

Authors: Lee DW, Anderson ME, Wu S, Lee JH
Citation: Arch Otolaryngol Head Neck Surg 2008 Dec 134 12: 1316-1323

read more

The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis

Authors: Derrick SC, Perera LP, Dheenadhayalan V, Yang A, Kolibab K, Morris SL
Citation: Vaccine 2008 Nov 11 26 48: 6092-6098

read more

Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies

Authors: Lo CY, Wu Z, Misplon JA, Price GE, Pappas C, Kong WP, Tumpey TM, Epstein SL
Citation: Vaccine 2008 Apr 16 26 17: 2062-2072

read more

Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1

Authors: Tompkins SM, Zhao ZS, Lo CY, Misplon JA, Liu T, Ye Z, Hogan RJ, Wu Z, Benton KA, Tumpey TM, Epstein SL
Citation: Emerg Infect Dis 2007 Mar 13 3: 426-435

read more

Adenovirus-mediated gene therapy enhances parainfluenza virus 3 infection in neonatal lambs

Authors: Meyerholz DK, Grubor B, Gallup JM, Lehmkuhl HD, Anderson RD, Lazic T, Ackermann MR
Citation: J Clin Microbiol 2004 Oct 42 10: 4780-4787

read more